Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1988-06-03
1992-11-10
Doll, John
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
43524027, 435 7021, 435 723, 5303888, C07K 1528, C12N 520, C12P 2108
Patent
active
051625040
ABSTRACT:
Monoclonal antibodies to prostatic cells, are produced by a hybridoma formed by fusing mouse lymphocytes and mouse myeloma cells. The monoclonal antibodies show specificity for a non-soluble, membrane associated, organ specific antigenic determinant limited in its distribution to normal and neoplastic, human prostate epithelial cells. The monoclonal antibodies, specifically 7E11-C5 monoclonal antibodies, may be suitable for diagnostic uses.
REFERENCES:
Wright et al., Cancer Res. 43:5509-16, 1983.
Horoszewicz et al., Anticancer Res. 7:927-36, 1987.
Frankel et al., PNAS 79:903-907, 1982.
Webb et al., Cancer Immunol Immunother 17:7-17, 1984.
Finstad et al., PNAS 82:2955-59, 1985.
Campbell "Monoclonal Antibody Technology" Elsevier Publ. 1984, 265 pages.
Cytogen Corporation
Doll John
Hutzell Paula
LandOfFree
Monoclonal antibodies to a new antigenic marker in epithelial pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies to a new antigenic marker in epithelial pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to a new antigenic marker in epithelial pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2294853